Metabolism and pharmacokinetics of 1-(2′-hydroxyethyl)- and 1-(3′-hydroxypropyl)-2-ethyl-3-hydroxypyridin-4-ones in the rat

This publication has 13 references indexed in Scilit:

• Therapeutic iron-chelating agents
  New Comprehensive Biochemistry, 1994
• Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential
  Journal of Medicinal Chemistry, 1993
• Long‐term assessment of efficacy and safety of L₁, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial
  British Journal of Haematology, 1992
• Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones.
  1992
• The Development of Hydroxypyridin‐4‐ones as Orally Active Iron Chelators
  Annals of the New York Academy of Sciences, 1990
• L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia major
  British Journal of Haematology, 1990
• Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients
  The Lancet, 1990
• Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
  BMJ, 1987
• PREVENTION OF IRON LOADING IN TRANSFUSION-DEPENDENT THALASSÆMIA
  The Lancet, 1978
• Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload
  New England Journal of Medicine, 1977